What Do High Calcitonin Levels Mean?

High calcitonin levels most often raise concern about medullary thyroid carcinoma (MTC), a cancer of the thyroid’s C cells, but the majority of mildly elevated readings turn out to have a non-cancerous explanation. Calcitonin is a hormone made by specialized cells in the thyroid gland, and its blood level can rise due to kidney disease, certain medications, pregnancy, smoking, and even laboratory error. The clinical challenge is sorting out which elevated result demands urgent action and which calls for watchful monitoring, a process that depends heavily on how high the number actually is, the patient’s sex, and whether the level is rising over time.

What Calcitonin Does in the Body

Calcitonin is a small hormone produced by the C cells (also called parafollicular cells) of the thyroid gland.¹ Its primary job is regulating bone turnover and calcium metabolism, working as a counterpart to parathyroid hormone.² Where parathyroid hormone pulls calcium out of bone and into the bloodstream, calcitonin does roughly the opposite: it slows bone breakdown and nudges calcium levels downward. In practice, though, day-to-day calcium balance in adults depends far more on parathyroid hormone and vitamin D than on calcitonin. Some researchers have called calcitonin “the forgotten hormone” because people who have had their thyroid removed and produce essentially no calcitonin still manage calcium just fine.

Still, the C cells that make calcitonin matter enormously in clinical medicine, because when those cells turn malignant they keep producing the hormone in large amounts. That is why a blood test showing elevated calcitonin can be an early signal of medullary thyroid carcinoma, and why doctors order the test in the first place.

Medullary Thyroid Carcinoma, the Primary Concern

MTC accounts for a small fraction of all thyroid cancers, but it is more aggressive than the common papillary and follicular types and does not respond to radioactive iodine. Because C cells pump out calcitonin even when they are cancerous, a blood calcitonin level acts as a surprisingly sensitive tumor marker. A basal calcitonin above about 100 pg/mL carries close to 100 percent positive predictive value for MTC in studies that have examined this threshold.³ At that level, the diagnosis is almost certain before a surgeon ever picks up a scalpel.

Lower elevations are murkier. Basal calcitonin between roughly 8 and 100 pg/mL in men or 6 and 80 pg/mL in women sits in a gray zone where MTC is possible but many other explanations exist.³ In one study, a basal calcitonin cut-off of about 46.5 pg/mL gave 100 percent specificity for distinguishing MTC from benign nodular goiter, though sensitivity was lower at 74 percent.⁴ In other words, a value that high strongly points toward cancer, but some MTC patients will still have values below that line.

Gender-specific thresholds also matter for diagnosis. One large diagnostic study found that MTC was predicted in men when basal calcitonin exceeded about 43 pg/mL and in women when it exceeded about 23 pg/mL.⁵ The gap reflects the fact that men normally run higher calcitonin levels than women, a pattern that persists across populations and assay types.

Why Calcitonin Doubling Time Matters More Than a Single Number

If you have been diagnosed with MTC and had surgery, one of the strongest predictors of how the disease will behave is how fast your calcitonin level doubles after treatment. A landmark study found that patients whose calcitonin doubled in less than six months had five-year survival of just 25 percent. Those whose calcitonin doubled between six months and two years fared better, and every single patient with a doubling time longer than two years was still alive at the end of follow-up.⁶ In that analysis, calcitonin doubling time was the only independent predictor of survival, outperforming even initial cancer staging.

More recent work confirms the pattern. High-grade MTC tumors show calcitonin doubling times averaging about 8.5 months, compared with roughly 38 months in low-grade tumors.⁷ Separate research found that calcitonin levels above about 4,020 pg/mL, combined with a doubling time under roughly 24 months, were associated with progressive disease.⁸ For anyone living with MTC, the trend in calcitonin over serial blood draws is far more informative than any single measurement.

Stimulation Tests and How They Fit In

When a basal calcitonin falls in the gray zone, clinicians sometimes order a stimulation test to see how much calcitonin the C cells can release when provoked. Historically this was done with pentagastrin, a synthetic hormone fragment that strongly stimulates C cells. In settings where pentagastrin is unavailable, an intravenous calcium infusion serves the same purpose. The idea is that cancerous or pre-cancerous C cells will produce a dramatic spike in calcitonin, while normal C cells respond more modestly.

One study using pentagastrin stimulation found that a peak calcitonin above 285 pg/mL gave 100 percent specificity and 82 percent sensitivity for MTC, while a peak above 290 pg/mL reached 100 percent on both measures.⁴ However, the real-world value of stimulation tests has come under scrutiny. Research comparing basal calcitonin alone against stimulated calcitonin found that newer high-sensitivity assays make the basal measurement accurate enough on its own, with combining both tests adding no meaningful diagnostic improvement.⁹ A general rule from the literature is that if the stimulated calcitonin rises less than twofold above baseline, MTC is unlikely, and the workup should pivot toward other explanations.³

Benign and Non-Cancer Causes of Elevated Calcitonin

A mildly elevated calcitonin level can stem from several conditions that have nothing to do with thyroid cancer. Recognizing these is crucial because misinterpretation can lead to unnecessary surgery.

• Chronic kidney disease: The kidneys are the primary site where calcitonin is broken down and cleared from the blood. When kidney function declines, calcitonin lingers longer in circulation. Dialysis patients routinely show elevated calcitonin levels, partly from reduced clearance and partly from increased C-cell activity in the setting of disordered calcium and parathyroid hormone regulation.¹⁰ Even patients with moderate kidney impairment who are not yet on dialysis can show significantly higher circulating calcitonin compared with people who have normal kidney function.¹¹
• Acid-suppressing medications: Proton pump inhibitors and H2 blockers raise gastrin levels over time, and gastrin is one of the signals that stimulates C cells. One study found that people who had been on these drugs long-term, as well as patients with pernicious anemia (another condition that chronically elevates gastrin), had significantly higher baseline and stimulated calcitonin levels than controls.¹² The effect is real but usually modest, and at least one other study did not find a significant increase in calcitonin from PPI use.¹³ The conflicting data suggest the elevation may depend on the duration and degree of gastrin stimulation.
• Pregnancy: About 72 percent of pregnant women in one study had calcitonin levels above the normal range, with elevations appearing across all trimesters and persisting into the first two days after delivery.¹⁴ The prevailing theory is that higher calcitonin helps protect the mother’s skeleton while the fetus draws heavily on her calcium stores. Other work has confirmed a rise in calcitonin during the second trimester, with levels tapering in the third trimester and during lactation.¹⁵
• Smoking: Smokers consistently show higher calcitonin than non-smokers. In a Korean population study, the suggested upper reference limit for current male smokers was 7.9 pg/mL compared with 5.7 pg/mL for male non-smokers.¹⁶ That gap may not sound dramatic, but it can push a smoker’s reading above a reference range calibrated to the general population and trigger unnecessary alarm.

Autoimmune thyroid disease (Hashimoto’s thyroiditis) and common papillary thyroid cancer, by contrast, do not appear to raise calcitonin. A study of over a thousand patients found no difference in calcitonin levels between those with and without Hashimoto’s thyroiditis, and the presence of papillary thyroid cancer larger than 1 cm also had no impact.¹⁷ If you have Hashimoto’s or a papillary thyroid nodule and your calcitonin comes back high, the elevation is not explained by those conditions and still needs investigation.

Men vs. Women and Normal Baseline Differences

One of the most consistent findings across populations is that men have higher calcitonin than women. Early research measured mean basal levels of 49 pg/mL in men versus 31 pg/mL in women.¹⁸ Newer assays produce lower absolute numbers but the ratio holds: a large European reference study found that the highest calcitonin values were about twice as high in men as in women, and also confirmed that smokers ran higher than non-smokers.¹⁹ Body mass index correlates with calcitonin in men as well. The upshot is that a calcitonin value of, say, 12 pg/mL means something different in a slim non-smoking woman than it does in an overweight male smoker. Context determines whether a number is concerning.

When High Calcitonin Comes from Outside the Thyroid

Calcitonin is classically a thyroid marker, but neuroendocrine tumors elsewhere in the body can also produce it. Ectopic calcitonin secretion has been reported in tumors of the lung, breast, prostate, liver, pancreas, and thymus.²⁰ These cases are uncommon, but they create a genuine diagnostic trap: a patient walks in with a high calcitonin and a thyroid nodule, everyone assumes MTC, and the thyroid gets removed, only for the calcitonin to stay elevated because the real source was elsewhere.

Two case reports of calcitonin-secreting pancreatic tumors found in patients with thyroid nodules illustrate the risk. Both patients were flagged because of marked hypercalcitoninemia, and in both cases the elevated calcitonin turned out to come from pancreatic neuroendocrine tumors, not from the thyroid.²¹ The authors stressed that awareness of ectopic sources could prevent unnecessary thyroidectomy. A case of a large-cell neuroendocrine lung carcinoma secreting calcitonin in an older woman further underscores that these tumors can show up in unexpected demographics.²²

The Inherited Cancer Syndromes

Some people have a genetic predisposition to develop MTC as part of a broader cancer syndrome called multiple endocrine neoplasia type 2 (MEN2). MEN2 is caused by inherited mutations in the RET gene and comes in subtypes, all of which carry a risk of MTC.²³ In these families, calcitonin screening starts in childhood, and a rising calcitonin level in a child who carries the mutation may prompt preventive thyroid removal before cancer has a chance to develop. If you are told your calcitonin is high and you also have a family history of thyroid cancer, pheochromocytoma, or hyperparathyroidism, genetic testing for RET mutations becomes part of the evaluation.

False Alarms from Lab Interference

Perhaps the most anxiety-inducing scenario is getting a sky-high calcitonin result that turns out to be completely wrong. Heterophilic antibodies, which are rogue antibodies in a patient’s blood that interfere with laboratory immunoassays, can produce wildly elevated calcitonin readings. In one striking case, a woman’s calcitonin came back at 3,199 pg/mL, a number that would ordinarily signal advanced MTC. Yet she had no thyroid nodules on ultrasound, and when the lab treated her sample with a heterophilic blocking agent, the calcitonin dropped to less than 0.1 pg/mL.²⁴

This is not a one-off curiosity. A screening study of 378 patients with thyroid nodules identified heterophilic antibody interference in about 1.3 percent, with four of five cases producing clinically relevant false-positive calcitonin results. In that particular series, false-positive calcitonin from antibody interference was actually more common than actual MTC.²⁵ The practical lesson: when calcitonin is very high but nothing else fits, the lab can run serial dilutions or use blocking agents to check whether the result is real. A mismatch between a dramatic lab value and an unremarkable clinical picture should always raise suspicion of assay interference.

Procalcitonin as a Related but Distinct Marker

Procalcitonin is calcitonin’s precursor molecule, and it has gained a reputation as a marker for bacterial sepsis. In severe infections, tissues all over the body release procalcitonin into the blood. But procalcitonin also rises in MTC, because the same C cells that make calcitonin also release its precursor. Because procalcitonin is more chemically stable than calcitonin and less prone to degradation in the blood, some researchers have explored it as an alternative or complementary marker for managing MTC.²⁶ If your doctor checks both calcitonin and procalcitonin at the same time, that dual approach can help distinguish between MTC, infection, and other causes of elevation.

Calcitonin as a Therapeutic Agent

In an ironic twist, calcitonin itself has been used as a medication. Salmon calcitonin, which is structurally similar to human calcitonin but more potent, was used for decades to treat osteoporosis and is still sometimes prescribed for bone loss in specific populations, such as dialysis patients at risk of renal osteodystrophy. If you receive calcitonin injections or nasal spray, your blood calcitonin level will be elevated as a direct result of the treatment. This is an obvious but sometimes overlooked cause of a high reading, particularly if a clinician orders a calcitonin blood test without knowing the patient is on the drug.

Knockout mouse studies have added an interesting wrinkle to our understanding of calcitonin’s skeletal role. Mice engineered to lack the calcitonin gene actually showed increased bone mass and bone formation rather than the bone loss you might expect, raising questions about whether the hormone’s primary role in mammals is really about protecting bone or about something else entirely.¹ The existence of calcitonin receptors on osteocytes suggests the hormone’s effects on bone may be more nuanced than the simple “it prevents bone breakdown” story found in textbooks.

What to Expect During the Workup

If your calcitonin comes back elevated, the path forward depends on the level and the clinical picture. A very high basal level (above 100 pg/mL) points strongly toward MTC and usually leads directly to thyroid ultrasound and fine-needle aspiration. Values in the gray zone will likely prompt a repeat test, a review of your medication list, a check of kidney function, and potentially a stimulation test. Your doctor should also ask about smoking, pregnancy, and family history of endocrine cancers.

When calcitonin is only mildly elevated and no thyroid nodule is found on imaging, the best approach is often serial monitoring every six to twelve months. A stable, mildly high level over years is reassuring; a steadily climbing one demands more aggressive investigation even if each individual value looks only modestly abnormal. The trajectory tells a story that no single blood draw can.

If the clinical picture does not match the lab result at all, ask about assay interference. Many labs have protocols for checking this, but they will not do it unless prompted. A clinician who sees a calcitonin of several thousand in a patient with a perfectly normal thyroid ultrasound should not rush to surgery. They should send the sample back to the lab with a request for dilution testing and heterophilic antibody evaluation.